| Date | Form | Description | Docs | XBRL | Pages |
| 03/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 03/10/23 | 8-K | Current report filing |
|
|
24 |
| 01/27/23 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
27 | |
| 01/04/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
40 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...